The evaluation of new psychoactive drugs

被引：1
|
作者：
Mueller, Christian P. [1 ]
Hassan, Zurina [2 ]
机构：
[1] Friedrich Alexander Univ, Univ Clin, Dept Psychiat & Psychotherapy, Erlangen Nuremberg Schwabachanlage 6, D-91054 Erlangen, Germany
[2] Univ Sains Malaysia, Ctr Drug Res, George Town 11800, Penang, Malaysia
来源：
BRAIN RESEARCH BULLETIN | 2016年 / 126卷
关键词：
SYNTHETIC CANNABINOIDS; NEUROBIOLOGY; KRATOM; MITRAGYNINE; ADDICTION; MOTIVES; ALCOHOL; HUMANS; SPICE;
D O I：
10.1016/j.brainresbull.2016.05.013
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [31] POISONING WITH PSYCHOACTIVE DRUGS
    TEITELBAUM, DT
    PEDIATRIC CLINICS OF NORTH AMERICA, 1970, 17 (03) : 557 - +
  • [32] Psychoactive drugs and skin
    Hautmann, G
    Lotti, T
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2003, 17 (04) : 383 - 393
  • [33] PSYCHOACTIVE-DRUGS
    LIEBHOLD, AM
    MEDICAL JOURNAL OF AUSTRALIA, 1975, 2 (03) : 110 - 110
  • [34] PSYCHOACTIVE-DRUGS
    SAMOTIN, SL
    CHEMICAL & ENGINEERING NEWS, 1991, 69 (04) : 5 - 5
  • [35] PSYCHOACTIVE DRUGS IN PEDIATRICS
    LOURIE, RS
    PEDIATRICS, 1964, 34 (05) : 691 - &
  • [36] The health threat of drugs of abuse adulteration by new psychoactive substances
    Minutillo, A.
    Palmi, I.
    Mastrobattista, L.
    CLINICA TERAPEUTICA, 2019, 170 (06): : E425 - E426
  • [37] ISMP: new 2018 data on use of three psychoactive drugs
    Reactions Weekly, 2019, 1748 (1) : 3 - 3
  • [38] New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs
    Helander, Anders
    Backberg, Matilda
    CLINICAL TOXICOLOGY, 2017, 55 (01) : 1 - 3
  • [39] RESPONDING TO NEW PSYCHOACTIVE SUBSTANCES IN THE ALCOHOL AND OTHER DRUGS SECTOR
    Brien, Rita
    Crafti, Naomi
    Grigg, Jasmin
    Dunn, Matthew
    Manning, Victoria
    DRUG AND ALCOHOL REVIEW, 2019, 38 : S31 - S32
  • [40] A NEW METHOD FOR THE EVALUATION OF PSYCHOACTIVE DRUG ACTIVITY
    DELAUNOIS, AL
    PEETROONS, C
    VANROMPU, E
    VANDERHEEREN, F
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1981, 3 (03): : 141 - 147
12345